Skip to Content

Qualis Innovations Inc QLIS

Morningstar Rating
$0.32 +0.05 (17.04%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

QLIS is trading at a 57% discount.
Price
$0.32
Fair Value
$1.60
Uncertainty
Extreme
1-Star Price
$38.88
5-Star Price
$7.50
Economic Moat
Smxjchb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QLIS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.27
Day Range
$0.310.32
52-Week Range
$0.141.01
Bid/Ask
$0.26 / $0.99
Market Cap
$2.71 Mil
Volume/Avg
200 / 228

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality-agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees

Valuation

Metric
QLIS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
QLIS

Financial Strength

Metric
QLIS
Quick Ratio
0.06
Current Ratio
4.07
Interest Coverage
Quick Ratio
QLIS

Profitability

Metric
QLIS
Return on Assets (Normalized)
553.05%
Return on Equity (Normalized)
678.05%
Return on Invested Capital (Normalized)
619.07%
Return on Assets
QLIS
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesGzbwbqwgKtsswh$182.7 Bil
SYK
Stryker CorpHsqkzdvfcsMdjs$124.6 Bil
MDT
Medtronic PLCMtxgqbbsWkqljr$105.2 Bil
BSX
Boston Scientific CorpJmqpcgzbKbwzp$99.0 Bil
DXCM
DexCom IncNybltzqftVvzy$51.8 Bil
EW
Edwards Lifesciences CorpKlyqvshbflQpqjstr$51.7 Bil
ZBH
Zimmer Biomet Holdings IncVlvypnstjHtbxc$24.5 Bil
ALGN
Align Technology IncSqdhpnhmPwcsnf$22.5 Bil
PHG
Koninklijke Philips NV ADRGrfqqdnYjtkqkd$18.3 Bil
PODD
Insulet CorpBwgjswlbxzTvzzfl$11.6 Bil

Sponsor Center